Status:
COMPLETED
Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations
Lead Sponsor:
Hospital St. Joseph, Marseille, France
Conditions:
Pancreatitis, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to assess the efficacy of the SpyGlass DS for the detection of residual pancreatic calculations after endoscopic treatment.
Eligibility Criteria
Inclusion
- aged 18 and over;
- with chronic calcifying pancreatitis;
- having already received endoscopic treatment for pancreatic pain related to stenosis and / or pancreatic stones;
- having given free, informed and written consent;
- being affiliated to a social security scheme or beneficiary of such a scheme.
Exclusion
- contraindications to performing an upper digestive endoscopy;
- haemorrhagic disease, haemostasis and coagulation disorder (PR \<60%, PTT\> 40 s and platelets \<60,000 / mm3;
- pregnant or breastfeeding woman;
- adult patient protected (guardianship or curatorship), or deprived of liberty by a judicial or administrative decision;
- person subject to a safeguard measure.
Key Trial Info
Start Date :
July 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2024
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04672642
Start Date
July 12 2021
End Date
March 13 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Saint Jospeh Marseille
Marseille, France